Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.67 -0.02 (-0.43%)
At close: Sep 30, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Interest Expenses (2023 - 2024)

Updated

Oramed Pharmaceuticals' Interest Expenses was $853,000 in FY2024, down 58.1% from $2.04 million in FY2023.

Analysis

Oramed Pharmaceuticals (ORMP) Interest Expenses (2023 - 2024) Analysis & Trends

  • Per Business Quant data, Interest Expenses in earlier years was $2.04 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Oramed Pharmaceuticals 192.94 Mn 192.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 261,000.00
Mar 31, 2024 592,000.00
Dec 31, 2023 1.21 Mn
Sep 30, 2023 826,000.00
API Access

Oramed Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ORMP&period=max&api_key=YOUR_API_KEY